News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Ad-hoc releases

Blitz F16-83 GmbH to launch takeover offer for Epigenomics AG

PDF   April 26, 2017 – Epigenomics AG (FSE: ECX; OTCQX: EPGNY) (“Epigenomics” or “Company”), Cathay Fortune International Company Limited (“CFIC”) and Blitz F16-83 GmbH (in the future Summit Hero Holding GmbH, “Bidder”), a subsidiary of CFIC, have tonight entered into a business combination agreement (“BCA”) regarding the takeover of Epigenomics by the Bidder. Other than by […]

Read more

Epigenomics AG issues new shares by way of private placement

PDF Publication of Inside Information according to Article 17 MAR Epigenomics AG issues new shares by way of private placement Not for distribution in the United States of America Berlin, Germany, November 16, 2016 – Epigenomics AG, Berlin, Germany (Prime Standard Segment, Frankfurt: ECX, ISIN: DE0000A11QW50), announces that the Company is raising EUR 2.1 million of gross […]

Read more

Epigenomics AG issues new shares by way of private placement

PDF Publication of Inside Information according to Article 17 MAR Epigenomics AG issues new shares by way of private placement Not for distribution in the United States of America Berlin, Germany, November 7, 2016 – Epigenomics AG, Berlin, Germany (Frankfurt Prime Standard: ECX, ISIN: DE0000A11QW50), announces that the Company is raising close to EUR 5.0 million of […]

Read more

Supervisory Board of Epigenomics AG appoints Gregory Hamilton as Chief Executive Officer (CEO)

PDF Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Supervisory Board of Epigenomics AG appoints Gregory Hamilton as Chief Executive Officer (CEO) Berlin, Germany, June 30, 2016 – The Supervisory Board of Epigenomics AG, Berlin, Germany (Frankfurt Prime Standard: ECX, ISIN: DE0000A11QW50) has today appointed Gregory Hamilton as Chief Executive Officer with […]

Read more

Epigenomics AG issues new shares by way of private placement

PDF Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Epigenomics AG issues new shares by way of private placement Not for distribution in the United States of America Berlin, Germany, May 24, 2016 – Epigenomics AG, Berlin, Germany (Frankfurt Prime Standard: ECX, ISIN: DE0000A11QW50), announces that the Company is raising around EUR 6.8 million […]

Read more

Epigenomics enters strategic license and development agreement with BioChain on novel, blood-based lung cancer test for China

PDF 202 KB   Berlin, Germany, March 30, 2016 – Epigenomics AG, Berlin, Germany, (Frankfurt Prime Standard: ECX; ISIN: DE000A11QW50) announces that it has entered a strategic license agreement with BioChain on the development and commercialization of a novel, blood-based lung cancer test for China. BioChain will initiate a clinical trial to validate the lung cancer […]

Read more
...